Vivek Asati

3.6k total citations · 2 hit papers
96 papers, 2.7k citations indexed

About

Vivek Asati is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Vivek Asati has authored 96 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Organic Chemistry, 43 papers in Molecular Biology and 26 papers in Computational Theory and Mathematics. Recurrent topics in Vivek Asati's work include Synthesis and biological activity (40 papers), Computational Drug Discovery Methods (26 papers) and Cancer Mechanisms and Therapy (16 papers). Vivek Asati is often cited by papers focused on Synthesis and biological activity (40 papers), Computational Drug Discovery Methods (26 papers) and Cancer Mechanisms and Therapy (16 papers). Vivek Asati collaborates with scholars based in India, Saudi Arabia and Türkiye. Vivek Asati's co-authors include Sanjay Kumar Bharti, Debarshi Kar Mahapatra, Shalini Bajaj, Ghanshyam Das Gupta, Jagadish Singh, Partha Pratim Roy, Preeti Patel, Sushil K. Kashaw, Sushil Kumar Singh and Ratnesh Das and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Vivek Asati

90 papers receiving 2.7k citations

Hit Papers

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhi... 2015 2026 2018 2022 2016 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
    2016 473 citations Vivek Asati, Debarshi Kar Mahapatra et al. European Journal of Medicinal Chemistry profile →
  2. Anti-cancer chalcones: Structural and molecular target perspectives
    2015 408 citations Debarshi Kar Mahapatra, Sanjay Kumar Bharti et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivek Asati India 23 1.4k 1.1k 337 290 275 96 2.7k
Sanjay Kumar Bharti India 24 1.4k 1.0× 1.4k 1.3× 421 1.2× 197 0.7× 236 0.9× 64 3.1k
Hamad M. Alkahtani Saudi Arabia 26 1.2k 0.8× 1.0k 1.0× 375 1.1× 245 0.8× 152 0.6× 137 2.3k
Rajesh N. Gacche India 29 867 0.6× 987 0.9× 324 1.0× 153 0.5× 305 1.1× 105 2.7k
Piyush Trivedi India 26 1.0k 0.7× 993 0.9× 240 0.7× 193 0.7× 221 0.8× 144 2.5k
Suresh Thareja India 22 759 0.5× 839 0.8× 227 0.7× 259 0.9× 143 0.5× 100 2.0k
Khaled A. M. Abouzid Egypt 36 2.4k 1.6× 1.5k 1.4× 505 1.5× 290 1.0× 475 1.7× 158 3.8k
Raj Kumar India 37 2.7k 1.9× 1.6k 1.5× 354 1.1× 229 0.8× 318 1.2× 121 4.5k
Huan‐Qiu Li China 27 1.4k 1.0× 837 0.8× 502 1.5× 153 0.5× 204 0.7× 68 2.4k
Parvez Κhan India 33 618 0.4× 1.6k 1.5× 523 1.6× 378 1.3× 286 1.0× 85 2.9k
Amitabh Jha Canada 23 1.2k 0.8× 1.2k 1.1× 415 1.2× 133 0.5× 347 1.3× 81 3.3k

Countries citing papers authored by Vivek Asati

Since Specialization
Citations

This map shows the geographic impact of Vivek Asati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Asati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Asati more than expected).

Fields of papers citing papers by Vivek Asati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Asati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Asati. The network helps show where Vivek Asati may publish in the future.

Co-authorship network of co-authors of Vivek Asati

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Asati. A scholar is included among the top collaborators of Vivek Asati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Asati. Vivek Asati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rashid, Mohd, Md. Shafiqul Islam, Balak Das Kurmi, et al.. (2025). Ball-mill-assisted mechanochemical approaches for heterocyclic compound synthesis (2015–2024). Molecular Diversity. 30(1). 3–40. 2 indexed citations
3.
Kumari, Anita, et al.. (2025). Unveiling the medicinal diversity of benzoic acid containing molecules: Insights on druggable targets for type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry. 128. 118245–118245. 1 indexed citations
4.
Asati, Vivek, et al.. (2025). Recent progress and structural insights of potential Hsp90 inhibitors as anticancer agents. Molecular Diversity. 29(6). 5335–5366. 1 indexed citations
5.
Dubey, Rahul, et al.. (2024). Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment. Bioorganic Chemistry. 149. 107508–107508. 7 indexed citations
6.
Kaya, Savaş, Farhan Siddique, Dilara Özbakır Işın, et al.. (2024). Inhibition performances of new pyrazole derivatives against the corrosion of C38 steel in acidic medium: Computational study. SHILAP Revista de lepidopterología. 14. 100184–100184. 27 indexed citations
7.
Singh, Gurpreet, et al.. (2024). Structural aspects of HIV-1 integrase inhibitors: SAR studies and synthetic strategies. Molecular Diversity. 29(5). 4963–4997. 2 indexed citations
8.
9.
Mehta, Ashish, et al.. (2024). Sustainable approaches to analyzing phenolic compounds: a green chemistry perspective. Analytical Sciences. 40(11). 1947–1968. 1 indexed citations
10.
11.
Ali, Amena, Abuzer Ali, Vivek Asati, Savaş Kaya, & Mohamed Jawed Ahsan. (2023). Design, synthesis and anti-hyperglycemic assessments of novel 5-benzylidenethiazolidine-2,4-dione derivatives as PPAR-γ agonist. Journal of the Indian Chemical Society. 100(11). 101100–101100. 10 indexed citations
12.
Dubey, Rahul, et al.. (2023). A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer. Bioorganic Chemistry. 143. 107077–107077. 10 indexed citations
13.
14.
Asati, Vivek, et al.. (2022). Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia. In Silico Pharmacology. 10(1). 7–7. 21 indexed citations
15.
Asati, Vivek, et al.. (2022). In silico studies for the identification of potential SGLT2 inhibitors. 14(4). 135–140. 3 indexed citations
16.
17.
Mahapatra, Debarshi Kar, Sanjay Kumar Bharti, & Vivek Asati. (2017). Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives. Current Topics in Medicinal Chemistry. 17(28). 3146–3169. 135 indexed citations
18.
Asati, Vivek, et al.. (2016). Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies. Current Pharmaceutical Design. 22(39). 6039–6054. 18 indexed citations
19.
Asati, Vivek, Debarshi Kar Mahapatra, & Sanjay Kumar Bharti. (2016). PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives. European Journal of Medicinal Chemistry. 109. 314–341. 473 indexed citations breakdown →
20.
Asati, Vivek, Debarshi Kar Mahapatra, & Sanjay Kumar Bharti. (2014). Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents. European Journal of Medicinal Chemistry. 87. 814–833. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanjay Kumar Bharti Breakdown of academic impact, for papers by Hamad M. Alkahtani Breakdown of academic impact, for papers by Rajesh N. Gacche Breakdown of academic impact, for papers by Piyush Trivedi Breakdown of academic impact, for papers by Suresh Thareja Breakdown of academic impact, for papers by Khaled A. M. Abouzid Breakdown of academic impact, for papers by Raj Kumar Breakdown of academic impact, for papers by Huan‐Qiu Li Breakdown of academic impact, for papers by Parvez Κhan Breakdown of academic impact, for papers by Amitabh Jha
Rankless by CCL
2026